Dr. Kalsi-Ryan is a Clinician Scientist in the field of neurological rehabilitation with a special interest in upper limb assessment, recovery, neurorestoration and spine pathology at KITE Research Institute-UHN, and is also Assistant Professor at the University of Toronto, Department of Physical Therapy. Her research is oriented to establishing methods to quantify neurological change after injury and studying neuro-restorative methods to enhance and optimize function for those with neurological impairment. Her current role is as the PI of the Upper Extremity Neuro-Restorative Innovations. She has established strong international collaborations and a culture of clinical research that fosters clinical practice and implementation. Her work is targetted towards enhancing clinical options and delivery of rehabilitation for people with neurotrauma, acquired brain and spinal cord injury and neurodegenerative impairments.
Dr. Kalsi-Ryan has an intense interest in neurorehabilitation and neuro-modulation techniques that can improve or restore function.She takes a special interest in positioning rehab professionals as the brokers of neuro-modulation technologies, especially in the area of implementation. Her lab is poised to function at the intersection of discovery, commercialization and implementation. Currently Dr. Kalsi-Ryan is leading the process to establish a Center of Excellence in NeuroModulation and NeuroRestoration. This center will provide a venue to educate clinicians, patients and support referrers in accessing many of these new and experimental rehab approaches.
Dr. Kalsi-Ryan provides academic teaching within the Neurosurgical Resident training, Rehabilitation Sciences Institute, Institute of Medical Sciences and Physical Therapy programs at the University of Toronto. She is the founder of her own company, which manufactures the GRASSP and she herself, acts as a consultant to device and pharmaceutical companies worldwide. Her interests include: outcome measurement, upper limb recovery, traumatic and non traumatic SCI, quantification of neurological disorders, implementation of new discoveries, accelerating discovery to commercialization and sustainability of research enterprises.